Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient

Hsiao Shan Cho; Kang Yun Lee; Chaur Jong Hu; Chen Chih Chung

doi:10.4103/0028-3886.227311

Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient

Hsiao Shan Cho, Kang Yun Lee, Chaur Jong Hu, Chen Chih Chung

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	509-511
Number of pages	3
Journal	Neurology India
Volume	66
Issue number	2
DOIs	https://doi.org/10.4103/0028-3886.227311
Publication status	Published - Mar 1 2018

ASJC Scopus subject areas

Neurology
Clinical Neurology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4103/0028-3886.227311

Cite this

@article{edc05f548bd1495cbece581962d3f4ce,

title = "Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient",

author = "Cho, {Hsiao Shan} and Lee, {Kang Yun} and Hu, {Chaur Jong} and Chung, {Chen Chih}",

year = "2018",

month = mar,

day = "1",

doi = "10.4103/0028-3886.227311",

language = "English",

volume = "66",

pages = "509--511",

journal = "Neurology India",

issn = "0028-3886",

publisher = "Medknow Publications and Media Pvt. Ltd",

number = "2",

}

TY - JOUR

T1 - Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient

AU - Cho, Hsiao Shan

AU - Lee, Kang Yun

AU - Hu, Chaur Jong

AU - Chung, Chen Chih

PY - 2018/3/1

Y1 - 2018/3/1

UR - http://www.scopus.com/inward/record.url?scp=85044242817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044242817&partnerID=8YFLogxK

U2 - 10.4103/0028-3886.227311

DO - 10.4103/0028-3886.227311

M3 - Letter

AN - SCOPUS:85044242817

SN - 0028-3886

VL - 66

SP - 509

EP - 511

JO - Neurology India

JF - Neurology India

IS - 2

ER -

Severe polyradiculoneuritis associated with the combination of ipilimumab and pembrolizumab in a lung cancer patient

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this